Ovarian Cancer:
Ovarian Cancer, news on ovarian caner, early detection of ovarian cancer and treatment, symptoms and signs of ovarian cancer, clinical trials and ovarian cancer information.
Ads by Google
-
Five years ago, Diem Brown experienced both extreme joy and deep despair. At age 23, she had recently landed her dream job as a freelance reporter for Associated Press and shortly thereafter, she was casted to compete on MTV’s Real World/Road Rules Challenge show. One month later, tragedy struck: she was diagnosed with ovarian cancer, an often fatal disease.
-
Avastin, generically known as bevacizumab, is found in two separate studies, published in the New England Journal of Medicine to extend progression free survival in women with the disease, combined with chemotherapy. Whether the drug improves overall survival is still being analyzed.
-
The European Commission’s approval is for use of Avastin as a first-line treatment together with standard chemotherapy, which includes carboplatin and paclitaxel, in women with advanced ovarian cancer. The approval is based on data from two clinical trials (ICON-7 and GOG 0218); these studies found that women who had Avastin added to their chemotherapy regimen and subsequently received Avastin alone experienced significantly-improved progression-free survival compared with those who received just the standard chemotherapy. The U.S. Food and Drug Administration (FDA) recently revoked approval of Avastin for breast cancer, citing that it is neither safe nor effective for that type of cancer.
-
Researchers have discovered ovarian cancer quickly spreads to fat pads within the abdomen where they can turn all of the cells into cancer. They also discovered when they inhibited a fat carrying protein, ovarian cancer tumors stopped growing.
-
A new study published in the British Journal of Cancer finds that women who have children or use hormonally-based birth control methods, such The Pill, have a reduced risk of ovarian cancer. While the exact reason is yet unknown, it is suspected that the decrease in risk is related to a reduction in the number of times a woman ovulates and menstruates in her lifetime.
-
Ovarian cancer affects one in 70 women, and when it strikes, it is often deadly. The reputation of ovarian cancer as a silent killer is still true, yet there are some signs and symptoms women should ow that can help with early detection.
-
The results of the second Phase II study involving AstraZeneca’s olaparib have been released, and the news is promising that the drug is a new treatment option for patients with a more common form of aggressive ovarian cancer.
-
Ovarian cancer is a formidable challenge to detect and treat, but now scientists have identified an antibody in the blood of infertile women that could eventually be used to screen for the disease in its early stages. Rush University Medical Center researchers detected a significant amount of the antibody on the surface of ovarian cancer cells.
-
The risk of a woman developing ovarian cancer increases from 1 in 70 to 1 in 11 if she has a mutated DNA repair gene called RAD51D. The newly discovered faulty gene may actually help researchers improve treatment possibilities as well as their understanding of cancer risks.
-
Ovarian cancer screenings have no effect on saving lives, says new study. According to researchers, women undergoing dual screenings for ovarian cancer have no decreased risk of mortality from this deadly disease. The study was conducted to see if comprehensive screening to detect the cancer at earlier and more curable stages would help reduce one's risk of dying.
